Norway: Introduction and subsequent termination of export ban on immunoglobulin following the outbreak of COVID-19

Announcement

28 May 2020

In May 2020, the Norwegian authorities introduced an export ban on immunoglobulin due to concerns of domestic shortages following the COVID-19 pandemic. The ban was terminated in June 2020.

Source

Number of interventions

1 certainly harmful

0 likely harmful

0 liberalising

List of interventions

Implementation date

28 May 2020

Revocation date:

26 Jun 2020

Updated: 28 May 2020

Export ban

On 28 May 2020, the Norwegian Medicines Agency introduced an export ban on immunoglobulin. The export ban was introduced due to concerns of domestic shortages following the COVID-19 outbreak. The g...

Related State Acts

26 Mar 2020

Norway: Introduction of export notification requirement on four COVID-19 related pharmaceutical products

Threads

See all

This state act is not part of any Thread yet.